175 related articles for article (PubMed ID: 12071579)
1. Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease.
Undas A; Brozek J; Musial J
Clin Lab; 2002; 48(5-6):287-96. PubMed ID: 12071579
[TBL] [Abstract][Full Text] [Related]
2. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
3. Statins and blood coagulation.
Undas A; Brummel-Ziedins KE; Mann KG
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):287-94. PubMed ID: 15569822
[TBL] [Abstract][Full Text] [Related]
4. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
5. Early vascular benefits of statin therapy.
Tsiara S; Elisaf M; Mikhailidis DP
Curr Med Res Opin; 2003; 19(6):540-56. PubMed ID: 14594527
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
März W; Köenig W
J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
[TBL] [Abstract][Full Text] [Related]
7. Statin withdrawal: clinical implications and molecular mechanisms.
Cubeddu LX; Seamon MJ
Pharmacotherapy; 2006 Sep; 26(9):1288-96. PubMed ID: 16945051
[TBL] [Abstract][Full Text] [Related]
8. Current questions regarding the use of statins in patients with coronary heart disease.
Rallidis LS; Lekakis J; Kremastinos DT
Int J Cardiol; 2007 Nov; 122(3):188-94. PubMed ID: 17399827
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
Patrick L; Uzick M
Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
[TBL] [Abstract][Full Text] [Related]
10. Statins in atherothrombosis.
Colli S; Werba JP; Tremoli E
Semin Vasc Med; 2004 Nov; 4(4):407-15. PubMed ID: 15861322
[TBL] [Abstract][Full Text] [Related]
11. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes.
Ray KK; Cannon CP
J Am Coll Cardiol; 2005 Oct; 46(8):1425-33. PubMed ID: 16226165
[TBL] [Abstract][Full Text] [Related]
12. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
13. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
Ray KK; Cannon CP; Ganz P
Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
Sharma R; Mahajan M; Singh B; Bal BS; Kant R
J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
[TBL] [Abstract][Full Text] [Related]
15. Statin therapy and the management of acute coronary syndromes.
Langer A; Constance C; Fodor JG; Frohlich JJ; Grégoire J; Lau DC; Leiter LA; Mancini GB; Marr D; McPherson R; O'Neill BJ; Rabkin SW
Can J Cardiol; 2003 Jul; 19(8):921-7. PubMed ID: 12876613
[TBL] [Abstract][Full Text] [Related]
16. Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy.
Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
Med Hypotheses; 2006; 66(5):1019-21. PubMed ID: 16188392
[TBL] [Abstract][Full Text] [Related]
17. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
Mason RP; Walter MF; Day CA; Jacob RF
Am J Cardiol; 2005 Sep; 96(5A):11F-23F. PubMed ID: 16126019
[TBL] [Abstract][Full Text] [Related]
18. Statins may be beneficial for patients with slow coronary flow syndrome due to its anti-inflammatory property.
Li JJ; Zheng X; Li J
Med Hypotheses; 2007; 69(2):333-7. PubMed ID: 17215087
[TBL] [Abstract][Full Text] [Related]
19. Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy.
Tamargo J; Caballero R; Gómez R; Núñez L; Vaquero M; Delpón E
Pharmacol Ther; 2007 Apr; 114(1):107-26. PubMed ID: 17287023
[TBL] [Abstract][Full Text] [Related]
20. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
